JB Jonas - Ophthalmic Res, 2006 - content.karger.com Background: Based on experimental studies and clinical observations by Robert
Machemer, Gholam Peyman and others, the vitreous cavity has increasingly been
used as a reservoir of drugs for the direct treatment of intraocular ... Cited by 46 - Related articles - BL Direct - All 5 versions
JB Jonas, B Harder, BA Kamppeter - American journal of ophthalmology, 2004 - Elsevier In the study group, visual acuity increased significantly (P ≤ .001) by 3.0 ±
2.6 Snellen lines to a peak at two to six months after the injection, and
decreased significantly (P = .001) towards the end of follow up. At the end ... Cited by 26 - Related articles - All 13 versions
E Ergun, N Maár, S Ansari-Shahrezaei, B … - American journal of ophthalmology, 2006 - Elsevier Mean follow-up was 15.9 months (range 12 to 30 months, median 15 months).
Twenty-three (38.3%) of 60 eyes had a stable result at 12 months' follow-up
(that is, loss/gain <three lines) and 34 (56.7%) of 60 had a loss of 3 ... Cited by 23 - Related articles - All 12 versions
WM Chan, TYY Lai, AL Wong, DTL Liu, DSC … - British Journal of Ophthalmology, 2007 - bjo.bmj.com Results: At 1 year, the logMAR best-corrected visual acuity (BCVA) for the
combined PDT with IVTA group changed from 0.62 to 0.61 (p = 0.74), whereas that
for the monotherapy group changed from 0.61 to 0.67 (p = 0.33). The mean ... Cited by 22 - Related articles - BL Direct - All 5 versions
JB Jonas, UH Spandau, B Harder, U … - American journal of ophthalmology, 2005 - Elsevier In the study group, visual acuity increased significantly (P < 0.001) from 0.96
± 0.32 logMar to a mean maximum of 0.76 ± 0.30 logMar during follow-up. An
increase in best visual acuity during follow-up was found in 18 (90%) eyes. ... Cited by 22 - Related articles - All 10 versions
W Eichler, Y Yafai, P Wiedemann, D Fengler - Current pharmaceutical design, 2006 - ingentaconnect.com Abstract: Neovascularization is a common and potentially visually threatening
complication of eye diseases such as dia- betic retinopathy (DR) and age-related
macular degeneration (AMD). An antiangiogenic therapy is aimed at ... Cited by 19 - Related articles - BL Direct - All 5 versions
JB Jonas, UH Spandau, BA Kamppeter, B … - Eye, 2006 - nature.com Visual acuity improved significantly (P<0.001) from baseline (0.90 0.45
logarithm of the minimum angle of resolution (LogMar)) to a mean minimum of 0.79
0.42 LogMar during follow-up. In 86 (38.7%) eyes and in 55 (24.8%) eyes, ... Cited by 16 - Related articles - BL Direct - All 4 versions
JB Jonas, F Schlichtenbrede - Eye, 2007 - nature.com Improvement in vision after intravitreal triamcinolone monotherapy is highest in
non-ischaemic diseases with an intraretinal macular oedema such as pseudophakic
cystoid macular oedema; it is lower in partially ischaemic diseases with ... Cited by 10 - Related articles - All 3 versions
